Gelteq Limited Ordinary Stock Performance
| GELS Stock | 0.89 0.07 7.29% |
The company retains a Market Volatility (i.e., Beta) of 1.43, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Gelteq Limited will likely underperform. At this point, Gelteq Limited Ordinary has a negative expected return of -0.63%. Please make sure to check out Gelteq Limited's maximum drawdown, as well as the relationship between the daily balance of power and period momentum indicator , to decide if Gelteq Limited Ordinary performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Gelteq Limited Ordinary has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's essential indicators remain comparatively stable which may send shares a bit higher in January 2026. The newest uproar may also be a sign of mid-term up-swing for the firm private investors. ...more
1 | Will Gelteq Limited stock deliver better than expected guidance - 2025 Market WrapUp Safe Entry Zone Tips - newser.com | 09/29/2025 |
2 | Short Interest in Gelteq Limited Declines By 80.9 | 10/17/2025 |
3 | Gelteq Announces Commencement of Preclinical Trial Targeting Oil Soluble Drug Market with Novel Delivery Platform | 10/23/2025 |
4 | Will Gelteq Limited stock reach all time highs in 2025 - Earnings Recap Summary Smart Money Movement Alerts - newser.com | 10/29/2025 |
5 | Why Gelteq Limited stock appeals to dividend seekers - July 2025 Gainers Precise Buy Zone Identification - newser.com | 11/06/2025 |
6 | Why Gelteq Limited stock appeals to dividend seekers - Market Trend Review Growth Focused Stock Reports - newser.com | 11/13/2025 |
7 | We Think Gelteq Has A Fair Chunk Of Debt | 11/24/2025 |
8 | Gelteq Preclinical Study Demonstrates Enhanced Oral Delivery of Oil-Soluble and Poorly Soluble Drugs Using Its Gel-Based Platform | 12/05/2025 |
9 | Gelteq Furthers Asia Presence Through Partnership with Hong Kong Flag Football Program | 12/16/2025 |
Gelteq Limited Relative Risk vs. Return Landscape
If you would invest 146.00 in Gelteq Limited Ordinary on September 18, 2025 and sell it today you would lose (57.00) from holding Gelteq Limited Ordinary or give up 39.04% of portfolio value over 90 days. Gelteq Limited Ordinary is currently does not generate positive expected returns and assumes 5.5251% risk (volatility on return distribution) over the 90 days horizon. In different words, 49% of stocks are less volatile than Gelteq, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Gelteq Limited Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Gelteq Limited's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Gelteq Limited Ordinary, and traders can use it to determine the average amount a Gelteq Limited's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1136
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | GELS |
Based on monthly moving average Gelteq Limited is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Gelteq Limited by adding Gelteq Limited to a well-diversified portfolio.
Gelteq Limited Fundamentals Growth
Gelteq Stock prices reflect investors' perceptions of the future prospects and financial health of Gelteq Limited, and Gelteq Limited fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Gelteq Stock performance.
| Return On Equity | -0.43 | ||||
| Return On Asset | -0.15 | ||||
| Operating Margin | (29.69) % | ||||
| Current Valuation | 13.18 M | ||||
| Shares Outstanding | 10.71 M | ||||
| Price To Book | 1.01 X | ||||
| Price To Sales | 24.92 X | ||||
| Revenue | 165.65 K | ||||
| Gross Profit | 297.74 K | ||||
| EBITDA | (3.84 M) | ||||
| Net Income | (6.65 M) | ||||
| Total Debt | 4.2 M | ||||
| Book Value Per Share | 1.05 X | ||||
| Cash Flow From Operations | (1.07 M) | ||||
| Earnings Per Share | (0.48) X | ||||
| Market Capitalization | 10.29 M | ||||
| Total Asset | 21.48 M | ||||
| Retained Earnings | (18.14 M) | ||||
| Working Capital | (4.13 M) | ||||
About Gelteq Limited Performance
Assessing Gelteq Limited's fundamental ratios provides investors with valuable insights into Gelteq Limited's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Gelteq Limited is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 639.21 | 430.60 | |
| Return On Tangible Assets | (12.75) | (12.11) | |
| Return On Capital Employed | (0.20) | (0.21) | |
| Return On Assets | (0.15) | (0.16) | |
| Return On Equity | (0.21) | (0.22) |
Things to note about Gelteq Limited Ordinary performance evaluation
Checking the ongoing alerts about Gelteq Limited for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Gelteq Limited Ordinary help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Gelteq Limited generated a negative expected return over the last 90 days | |
| Gelteq Limited has high historical volatility and very poor performance | |
| Gelteq Limited has some characteristics of a very speculative penny stock | |
| Gelteq Limited has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 165.65 K. Net Loss for the year was (6.65 M) with profit before overhead, payroll, taxes, and interest of 297.74 K. | |
| Gelteq Limited generates negative cash flow from operations | |
| About 48.0% of the company shares are held by company insiders | |
| Latest headline from MacroaxisInsider: Acquisition by Martin James Joseph of 300000 shares of Cocrystal Pharma at 0.42 subject to Rule 16b-3 |
- Analyzing Gelteq Limited's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Gelteq Limited's stock is overvalued or undervalued compared to its peers.
- Examining Gelteq Limited's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Gelteq Limited's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Gelteq Limited's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Gelteq Limited's stock. These opinions can provide insight into Gelteq Limited's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Gelteq Stock Analysis
When running Gelteq Limited's price analysis, check to measure Gelteq Limited's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gelteq Limited is operating at the current time. Most of Gelteq Limited's value examination focuses on studying past and present price action to predict the probability of Gelteq Limited's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gelteq Limited's price. Additionally, you may evaluate how the addition of Gelteq Limited to your portfolios can decrease your overall portfolio volatility.